MarketCap
Facebook
X
TelegramQuarterly report 2023-Q2
added 08-07-2023
Chinook Therapeutics Historical Prices 2011-2026 | KDNY
Annual Historical Prices Chinook Therapeutics
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 21.6 | 16.3 | 15.9 | 5.9 | 13.2 | 37.5 | 57 | 141 | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 141 | 5.9 | 38.5 |
Historical Prices of other stocks in the Biotechnology industry
| Issuer | Historical Prices | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
MorphoSys AG
MOR
|
18.2 | - | 2.43 % | $ 254 M |  Germany |
 |
Verastem
VSTM
|
5.83 | $ 5.04 | -4.73 % | $ 349 M |  USA |
 |
VistaGen Therapeutics
VTGN
|
2.38 | $ 0.57 | -5.87 % | $ 17.6 M | USA |
 |
Akero Therapeutics
AKRO
|
48.4 | - | - | $ 3.67 B | USA |
 |
I-Mab
IMAB
|
0.68 | - | - | $ 866 M |  China |
 |
Genfit SA
GNFT
|
3.36 | - | 2.54 % | $ 160 B |  France |
 |
Biophytis SA
BPTS
|
0.33 | - | -13.47 % | $ 169 M | France |
 |
Aileron Therapeutics
ALRN
|
2.13 | - | 10.36 % | $ 9.8 M | USA |
 |
Midatech Pharma plc
MTP
|
0.29 | - | -18.52 % | $ 27.3 M |  Britain |
 |
Aptinyx
APTX
|
0.14 | - | -39.0 % | $ 4.57 M | USA |
 |
Avenue Therapeutics
ATXI
|
0.42 | - | -52.27 % | $ 4.45 M | USA |
 |
Adaptive Biotechnologies Corporation
ADPT
|
16.4 | $ 12.41 | -11.1 % | $ 1.88 B | USA |
 |
Xenon Pharmaceuticals
XENE
|
38.5 | $ 54.48 | -1.89 % | $ 4.24 B |  Canada |
 |
BeiGene, Ltd.
BGNE
|
185 | - | 0.49 % | $ 251 B |  Cayman-islands |
 |
ChemoCentryx
CCXI
|
26.9 | - | - | $ 3.74 B | USA |
 |
Enochian Biosciences
ENOB
|
0.7 | - | - | $ 40.5 M | USA |
 |
CureVac N.V.
CVAC
|
19.3 | - | - | $ 867 M | Germany |
 |
Summit Therapeutics
SMMT
|
16.1 | $ 16.58 | -3.94 % | $ 12.4 B | Britain |
 |
Bellerophon Therapeutics
BLPH
|
8.23 | - | -74.18 % | $ 955 K | USA |
 |
Alnylam Pharmaceuticals
ALNY
|
311 | $ 317.36 | -3.29 % | $ 41.6 B | USA |
 |
Arbutus Biopharma Corporation
ABUS
|
4.42 | $ 4.29 | -3.6 % | $ 822 M | Canada |
 |
Allakos
ALLK
|
1.31 | - | - | $ 28.6 M | USA |
 |
Brickell Biotech
BBI
|
2.11 | - | -5.38 % | $ 6.06 M | USA |
 |
Allena Pharmaceuticals
ALNA
|
0.383 | - | 3.16 % | $ 1.9 M | USA |
 |
Calithera Biosciences
CALA
|
13.3 | - | -10.95 % | $ 876 K | USA |
 |
Fusion Pharmaceuticals
FUSN
|
21.1 | - | - | $ 1.41 B | Canada |
 |
Ampio Pharmaceuticals
AMPE
|
0.82 | - | -11.43 % | $ 502 K | USA |
 |
AlloVir
ALVR
|
9.78 | - | 4.14 % | $ 49.1 M | USA |
 |
Amphastar Pharmaceuticals
AMPH
|
26.7 | $ 19.01 | -2.66 % | $ 889 M | USA |
 |
Gritstone Oncology
GRTS
|
2.39 | - | 0.42 % | $ 213 M | USA |
 |
ACADIA Pharmaceuticals
ACAD
|
19.3 | $ 20.75 | -3.35 % | $ 3.44 B | USA |
 |
Aligos Therapeutics
ALGS
|
6.67 | $ 6.66 | -5.4 % | $ 65.8 M | USA |
 |
Aravive
ARAV
|
1.66 | - | -13.39 % | $ 1.45 M | USA |
 |
Alkermes plc
ALKS
|
31.1 | $ 29.39 | -1.77 % | $ 4.84 B |  Irlanda |
 |
Cabaletta Bio
CABA
|
2.82 | $ 2.68 | -4.96 % | $ 269 M | USA |
 |
AbbVie
ABBV
|
226 | $ 209.4 | -0.81 % | $ 370 B | USA |
 |
AbCellera Biologics
ABCL
|
3.22 | $ 3.27 | -2.39 % | $ 977 M | Canada |
 |
ARCA biopharma
ABIO
|
28.8 | - | 1052.0 % | $ 415 M | USA |
 |
Acer Therapeutics
ACER
|
0.77 | - | 2.71 % | $ 14 M | USA |
 |
Acorda Therapeutics
ACOR
|
13.5 | - | -24.86 % | $ 820 K | USA |
 |
Acasti Pharma
ACST
|
3.37 | - | 4.01 % | $ 150 M | Canada |
 |
Athira Pharma
ATHA
|
0.42 | - | - | $ 269 M | USA |
 |
Adverum Biotechnologies
ADVM
|
3.86 | - | - | $ 86.2 M | USA |